多参数磁共振中弥散加权与动态增强对临床显著前列腺癌检出的附加价值:PICTURE试验
PICTURE是一项配对队列确证性研究,纳入249例既往接受过非MRI引导经直肠超声引导活检、需进一步风险分层的男性,行3T多参数MRI(T2W、DWI、DCE)后行经会阴模板前列腺穿刺定位活检。按序贯盲法分别生成T2W、T2W+DWI、T2W+DWI+DCE的LIKERT评分,以LIKERT≥3为阳性阈值,比较各组合对临床显著前列腺癌的诊断准确性。结果显示,基于主要定义,T2W、T2W+DWI与T2W+DWI+DCE的AUROC分别为0.74、0.76与0.77,差异无统计学意义(P=0.55);但单用T2W时可疑病灶比例更高(44.6% vs 23.9% vs 19.8%)。
要点
- 在既往活检男性中,3T MRI单用T2W即可达到较高诊断准确性。
- 加用DWI或DCE未显著提高临床显著前列腺癌的总体诊断准确性。
- 单用T2W时可疑病灶比例更高,加用DWI和DCE可减少可疑病灶。
核心结论
- 在既往活检男性中,3T MRI单用T2W即可达到较高诊断准确性,但可疑病灶比例更高。
- 加用DWI或DCE未显著改善对临床显著前列腺癌的总体诊断准确性。
研究设计与样本
- PICTURE为配对队列确证性研究,纳入249例既往非MRI引导经直肠超声引导活检后需进一步风险分层的男性。
- 所有受试者行3T多参数MRI(T2W、DWI、DCE)后行经会阴模板前列腺穿刺定位活检。
- 按序贯盲法分别生成T2W、T2W+DWI、T2W+DWI+DCE的LIKERT评分,阳性阈值设为LIKERT≥3。
- 采用AUROC分析比较各组合的诊断准确性,临床显著前列腺癌采用包括UCL/Ahmed定义1(主要定义)在内的多种定义分析。
主要发现
- 249例中246例有可用的序贯MRI报告。
- 单用T2W时可疑病灶比例为44.6%,加用DWI后为23.9%,加用DCE后为19.8%。
- 基于主要定义,T2W的AUROC为0.74(95%CI 0.68-0.80),T2W+DWI为0.76(95%CI 0.71-0.82),T2W+DWI+DCE为0.77(95%CI 0.71-0.82),三者差异无统计学意义(P=0.55)。
- 采用其他临床显著疾病定义时AUROC值仍相当:UCL/Ahmed定义2(P=0.79)、Gleason≥3+4(P=0.53)、Gleason≥4+3(P=0.53)。
关键数值与推荐
- mpMRI阳性阈值设为LIKERT评分≥3。
- 临床显著前列腺癌主要定义采用UCL/Ahmed定义1,并分析UCL/Ahmed定义2、Gleason≥3+4、Gleason≥4+3等其他定义。
- 基于主要定义,T2W、T2W+DWI、T2W+DWI+DCE的AUROC分别为0.74、0.76、0.77,组间比较P=0.55。
- 单用T2W、加用DWI、加用DCE时可疑病灶比例分别为44.6%、23.9%、19.8%。
临床怎么用
- 在既往活检男性中,可考虑以T2W单参数作为3T MRI报告策略,但需注意可疑病灶比例较高。
- 加用DWI和DCE可减少可疑病灶比例,但未显著提高总体诊断准确性。
- 临床决策时应结合既往活检史及可疑病灶比例升高带来的潜在影响。
局限性
- 研究纳入的是既往活检后需进一步风险分层的男性,结论外推至其他人群需谨慎。
- 序贯MRI报告仅246/249例可用。
- 临床显著前列腺癌采用多种定义分析,主要定义结果与其它定义结果一致,但定义选择可能影响解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the additional diagnostic value of diffusion-weighted imaging (DWI) and dynamic contrast-enhanced imaging (DCE) in men requiring a repeat biopsy within the PICTURE study. PATIENTS AND METHODS: PICTURE was a paired-cohort confirmatory study in which 249 men who required further risk stratification after a previous non-magnetic resonance imaging (MRI)-guided transrectal ultrasonography-guided biopsy underwent a 3-Tesla (3T) multiparametic (mp)MRI consisting of T2-weighted imaging (T2W), DWI and DCE, followed by transperineal template prostate mapping biopsy. Each mpMRI was reported using a LIKERT score in a sequential blinded manner to generate scores for T2W, T2W+DWI and T2W+DWI+DCE. Area under the receiver-operating characteristic curve (AUROC) analysis was performed to compare the diagnostic accuracy of each combination. The threshold for a positive mpMRI was set at a LIKERT score ≥3. Clinically significant prostate cancer was analysed across a range of definitions including UCL/Ahmed definition 1 (primary definition), UCL/Ahmed definition 2, any Gleason ≥3 + 4 and any Gleason ≥4 + 3. RESULTS: Of 249 men, sequential MRI reporting was available for 246. There was a higher rate of equivocal lesions (44.6%) using T2W alone compared to the addition of DWI (23.9%) and DCE (19.8%). Using the primary definition of clinically significant disease, there was no significant difference in the overall accuracy between T2W, with an AUROC of 0.74 (95% confidence interval [CI] 0.68-0.80), T2W+DWI at 0.76 (95% CI 0.71-0.82), and T2W+DWI+DCE, with an AUROC of 0.77 (95% CI 0.71-0.82; P = 0.55). The AUROC values remained comparable using other definitions of clinically significant disease including UCL/Ahmed definition 2 (P = 0.79), Gleason ≥3 + 4 (P = 0.53) and Gleason ≥4 + 3 (P = 0.53). CONCLUSIONS: Using 3T MRI, a high level of diagnostic accuracy can be achieved using T2W as a single parameter in men with a prior biopsy; however, such a strategy can lead to a higher rate of equivocal lesions.
引用
- Eldred-Evans D, Neves JB, Simmons LAM, et al. Added value of diffusion-weighted images and dynamic contrast enhancement in multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer in the PICTURE trial. BJU Int. 2019. PMID: 31733173. doi:10.1111/bju.14953
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。